News

Novartis Pharmaceuticals Canada Inc. is pleased to announce that PrKesimpta® (ofatumumab) is now covered under the Ontario Exceptional Access Program (EAP) and included on the Régie de l’assurance maladie du Québec (RAMQ) List of Medications as an Exceptional Medication for...

The FDA's Office of Prescription Medicine Promotion (OPDP) intends to know how patients and doctors consider the risks and benefits of a new prescription medicine before starting it. What factors influence treatment decisions, and how do people choose one medication...

As worldwide demand dwindles, around 200 million doses of COVID-19 vaccine are rusting away in the world's largest vaccine manufacturer's warehouses. As per Bloomberg, Serum Institute of India (SII) CEO Adar Poonawalla revealed at the India Economic Conclave that they had ceased...

Sanofi's "factory of the future" in Singapore could be operational by the middle of the decade. One of two so-called Evolutive Vaccine Facilities (EVFs) that the French drugmaker is building with a collective investment of 900 million euros (about...

Lower mid-market private equity firm NorthEdge has completed its investment into life sciences marketing agency, ramarketing, to support rapid service expansion and increased international presence. North-East headquartered ramarketing employs more than 50 people globally with offices in Newcastle, Manchester and...

Samsung Biologics announced that it has completed the purchase of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion. With the completion of the first payment of USD $1.0 billion pursuant to the terms of the...

Last year, Novartis chose to purchase its way into the arena after the failure of its PD-1/L1 candidate, spartalizumab. So it reached a deal with China's BeiGene, paying $650 million up front and promising $1.55 billion in milestone payments in...